Award notice Supplies

Suministro del medicamento exclusivo: Tofersen (QALSODY).

Notice published in Spanish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Servicio Madrileño de Salud - Hospital Universitario La Paz
Madrid
Place of performance: Madrid
Amount awarded: €2,059,260 excl. VAT
Bids received: 1
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 10 September 2026
Notice language: Spanish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Suministro del medicamento exclusivo: Tofersen (QALSODY).

Awarded to

BIOGEN SPAIN S.L.

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €350,000
Median: €846,164
A quarter above: €2,267,877

Amounts awarded (excl. VAT) over the last 3 years for 265 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Suministro del medicamento exclusivo: Atogepant (AQUIPTA). Servicio Madrileño de Salud - Hospital Universitario La Paz · 1 October 2026	ABBVIE SPAIN, S.L.U.	€183,702
Adquisición de medicamentos exclusivos: ublituximab (briumvi). Servicio Madrileño de Salud - Hospital Universitario La Paz · 1 October 2026	NEURAXPHARM SPAIN S.L.	€215,941
Adquisición de medicamentos exclusivos: ramucirumab (cyramza). Servicio Madrileño de Salud - Hospital Universitario La Paz · 1 October 2026	Lilly S.A.	€252,236
Suministro del medicamento exclusivo: Eptacog alfa (NOVOSEVEN). Servicio Madrileño de Salud - Hospital Universitario La Paz · 18 September 2026	NOVO NORDISK PHARMA, S.A.	€1,498,940
Suministro del medicamento exclusivo: Givinostat (DUVYZAT). Servicio Madrileño de Salud - Hospital Universitario La Paz · 18 September 2026	ITALFARMACO, S.A	€1,235,071

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 624539-2026.